UNIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA AS A POTENTIAL PREDICTOR OF ARTERIAL HYPERTENSION DEVELOPMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
The article presents the results of studies of markers of connective tissue dysplasia and the content of the main fibroblast growth factor in blood plasma in patients with type 2 diabetes. The presence of significant correlations between the studied parameters with the occurrence and progression of hypertension in patients with type 2 diabetes is established. A regression model for predicting the development of arterial hypertension is proposed in patients with diabetes mellitus.
The development of hypertension in patients with DM type 2 in combination with UCTD occurs earlier, is almost independent of the duration of diabetes, more pronounced hypertension is observed in patients with visceral and skeletal symptoms of UCTD. This is evidence of the role of UCTD in the pathogenesis of hypertension in patients with type 2 diabetes.
Essential role in the emergence and progression of hypertension in patients with DM type 2 is played by metabolic disorders of the connective tissue that manifests as clinical signs of UCTD. FGF2, which content is increased in patients with visceral and/or skeletal symptoms of UCTD, is involved in its pathogenesis.
The regression model of the prediction of hypertension in patients with DM type 2 with an assessment of the presence of UCTD signs and the duration of diabetes has a high prognosticity, specificity and sensitivity, which makes it possible to apply this method in clinical practice to determine patients with high risk of development of hypertension.
Campbell, N. R., Lackland, D. T., Niebylski, M. L., & World Hypertension League and International Society of Hypertension Executive Committees. (2014). High blood pressure: why prevention and control are urgent and important – a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension. The Journal of Clinical Hypertension, 16(8), 551–553. Available from: http://ishworld.com/news/a/WHL-and-ISH-Hypertension-Fact-Sheet.
Movahed, M. R., et al. «Strong independent association between obesity and essential hypertension». Clinical obesity 6.3 (2016): 189–192.
Redon J., Martinez F., Fabia M. J. The metabolic syndrom in hypertension. Manual of hypertension of the European Society of Hypertension. Edited by G. Mancia, G. Grassi and J. Redon. CRC Press, 2014: 433– 442.
Sirenko Ju. N, Radchenko A. D., Slashheva T. G. Stratifikacija riska pacientov s arterial'noj gipertenziej i saharnym diabetom 2-go tipa: rezul'taty ukrainskogo mnogocentrovogo observacionnogo issledovanija Status. Arterial'naja gipertenzija. 2014; 2: 9–19.
Horr S., Nissen S. Managing hypertension in type 2 diabetes mellitus. Best Pract Res Clin Endocrinol Metab. 2016; 30(3):445–454. DOI: 10.1016/j.beem.2016. 06.001.
Mogil'nickaja L. A, Man'kovskij B. N. Soderzhanie jendotelial'nogo monocitaktivirujushhego peptida-II u bol'nyh saharnym diabetom 1 tipa s mikroangiopatijami i arterial'noj gipertenziej. Saharnyj diabet. 2016; 19(4):309–314 DOI: 10.14341/DM7674.
Woodward M, Huxley R, Ueshima H, Fang X. The Asia pacific cohort studies collaboration: a decade of achievements. Glob Heart. 2012 Dec;7(4):343–51.
Mandosi, Elisabetta, et al. «Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes». Expert opinion on therapeutic targets 19.12 (2015): 1617–1622.
Lüscher, Thomas F., et al. «Endothelial Dysfunction and Hypertension». Vascular Endothelium in Human Physiology and Pathophysiology. CRC Press, 2014. 125–146.
Lotfy, Mohamed, et al. «Chronic complications of diabetes mellitus: A mini review». Current diabetes reviews 13.1 (2017): 3–10.
Russo, Ilaria, and Nikolaos G. Frangogiannis. «Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities». Journal of molecular and cellular cardiology 90 (2016): 84–93.
Shakya S., Wang Y., Mack J. A., Maytin E. V. Hyperglycemia-induced changes in hyaluronan contribute to impaired skin wound healing in diabetes: review and perspective. Int J Cell Biol. 2015, Article ID 701738. http://dx.doi.org/10.1155/2015/701738.
Mohamed, Raafat, et al. «Transforming growth factor–β1 mediated CHST11 and CHSY1 mRNA expression is ROS dependent in vascular smooth muscle cells». Journal of Cell Communication and Signaling (2018): 1–9.
Papasotiriou, Marios, et al. «Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases». Nephrology Dialysis Transplantation 30.7 (2015): 1112–1121.
Kishi, Fumi, et al. «Urinary type IV collagen excretion is involved in the decline in estimated glomerular filtration rate in the Japanese general population without diabetes: A 5-year observational study». PloS one 13.4 (2018): e0195523.
Kadurina T. I, Gorbunova V. N. Displazija soedinitel'noj tkani. Rukovodstvo dlja vrachej. SPb, Jelbi-SPb, 2009. 704 s.
Gubanova M. V., Kalashnikova L. A., Dobrynina L. A., Shamtieva K. V., Berdalin A. B. Markery displazii soedinitel'noj tkani pri dissekcii magistral'nyh arterij golovy i provocirujushhie faktory dissekcii. Annaly klinicheskoj i jeksperimental'noj nevrologii. 2017; 11(4): 19–28. DOI: 10.18454/ACEN.2017.4.2.
Martynova A. I, Nechaeva G. I: red. Nacional'nye rekomendacii rossijskogo nauchnogo medicinskogo obshhestva terapevtov po diagnostike, lecheniju i reabilitacii pacientov s displazijami soedinitel'noj tkani. M.: OOO «Bionika-Media», 2016. 80 s.
Shivapour, Daniel M., Phillip Erwin, and Esther SH Kim. «Epidemiology of fibromuscular dysplasia: a review of the literature». Vascular Medicine 21.4 (2016): 376–381.
Alimova I. L., Pashinskaja N. B., Pleskachevskaja T. A. Osobennosti techenija saharnogo diabeta 1 tipa u detej i podrostkov na fone displazii soedinitel'noj tkani. Medicinskij vestnik Severnogo Kavkaza. 2016; 11(2): 272–275.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.